Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic
BASEL, Switzerland, September 26, 2019 / B3C newswire / -- T3 Pharmaceuticals AG (T3), a Basel (Switzerland)-based company focusing on immuno-oncology, closes its second financing round of over 12M CHF with existing investors joined by «Boehringer …